(VIANEWS) – HomeTrust Bancshares (HTBI), Paylocity Holding Corporation (PCTY), Ares Capital (ARCC) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. HomeTrust Bancshares (HTBI)
35.4% sales growth and 8.35% return on equity
HomeTrust Bancshares, Inc. operates as the bank holding company for HomeTrust Bank that provides a range of retail and commercial banking products and services. Its deposit products include savings, money market, and demand accounts, as well as certificates of deposit for individuals, businesses, and nonprofit organizations. The company's loan portfolio comprises retail consumer loans, such as one-to-four-family real estate lending, home equity lines of credit, construction and land/lots, indirect auto finance, and consumer lending; and commercial loans that include commercial real estate lending, construction and development lending, and commercial and industrial loans. It also provides small business administration loans, equipment finance leases, indirect automobile loans, and municipal leases; and cash management and online/mobile banking services. As of June 30, 2020, the company operated 41 offices in North Carolina, Upstate South Carolina, East Tennessee, and Southwest Virginia. HomeTrust Bancshares, Inc. was founded in 1926 and is headquartered in Asheville, North Carolina.
Earnings Per Share
As for profitability, HomeTrust Bancshares has a trailing twelve months EPS of $2.27.
PE Ratio
HomeTrust Bancshares has a trailing twelve months price to earnings ratio of 9.63. Meaning, the purchaser of the share is investing $9.63 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.35%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 128.9% and 36.7%, respectively.
2. Paylocity Holding Corporation (PCTY)
32% sales growth and 17.8% return on equity
Paylocity Holding Corporation provides cloud-based payroll and human capital management software solutions for medium-sized organizations in the United States. The company offers Payroll and Tax Services solution to simplify payroll, automate processes and manage compliance requirements within one system; expense management, on demand payment, and garnishment solutions; human capital management and employee self-service solutions, document library, compliance dashboard, and HR edge; time and attendance solution, which tracks time and attendance data, eliminating the need for manual tracking of accruals and reducing administrative tasks; schedule tracking services; and time collection devices, including kiosks, time clocks, and mobile and web applications. In addition, the company offers talent management solutions comprising recruiting and onboarding, as well as learning, performance, and compensation management; employee benefits management and third-party administrative solutions; modern workforce solutions consisting of community, premium video, survey, and peer recognition; and analytics and insights solutions covering modern workforce index, data insights, and reporting. Further, it provides implementation and training, client, and tax and regulatory services. The company's clients include for-profit and non-profit organizations across industries, including business services, financial services, healthcare, manufacturing, restaurants, retail, technology, and others. It sells its products through sales representatives. The company was founded in 1997 and is headquartered in Schaumburg, Illinois.
Earnings Per Share
As for profitability, Paylocity Holding Corporation has a trailing twelve months EPS of $2.11.
PE Ratio
Paylocity Holding Corporation has a trailing twelve months price to earnings ratio of 106.62. Meaning, the purchaser of the share is investing $106.62 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.8%.
Moving Average
Paylocity Holding Corporation’s value is way higher than its 50-day moving average of $183.08 and way above its 200-day moving average of $198.91.
Volume
Today’s last reported volume for Paylocity Holding Corporation is 319349 which is 34.99% below its average volume of 491286.
Sales Growth
Paylocity Holding Corporation’s sales growth is 31.8% for the current quarter and 32% for the next.
3. Ares Capital (ARCC)
22.7% sales growth and 6.87% return on equity
Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors. The fund will also consider investments in industries such as restaurants, retail, oil and gas, and technology sectors. It focuses on investments in Northeast, Mid-Atlantic, Southeast and Southwest regions from its New York office, the Midwest region, from the Chicago office, and the Western region from the Los Angeles office. The fund typically invests between $20 million and $200 million and a maximum of $400 million in companies with an EBITDA between $10 million and $250 million. It makes debt investments between $10 million and $100 million The fund invests through revolvers, first lien loans, warrants, unitranche structures, second lien loans, mezzanine debt, private high yield, junior capital, subordinated debt, and non-control preferred and common equity. The fund also selectively considers third-party-led senior and subordinated debt financings and opportunistically considers the purchase of stressed and discounted debt positions. The fund prefers to be an agent and/or lead the transactions in which it invests. The fund also seeks board representation in its portfolio companies.
Earnings Per Share
As for profitability, Ares Capital has a trailing twelve months EPS of $1.64.
PE Ratio
Ares Capital has a trailing twelve months price to earnings ratio of 11.93. Meaning, the purchaser of the share is investing $11.93 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.87%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Jun 13, 2023, the estimated forward annual dividend rate is 1.92 and the estimated forward annual dividend yield is 9.93%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 23.9% and 16%, respectively.
Volume
Today’s last reported volume for Ares Capital is 4057890 which is 36.32% above its average volume of 2976620.
Revenue Growth
Year-on-year quarterly revenue growth grew by 40.5%, now sitting on 2.27B for the twelve trailing months.
Previous days news about Ares Capital(ARCC)
- According to Zacks on Friday, 28 July, "Direct lending also continues to be increasingly active beyond the arena of the LBO market as direct lenders accomplished 1.5X as non-buyout financings as the broadly syndicated market during the second quarter, according to data by LCD, as quoted on the earnings transcript of Ares Capital (ARCC Quick QuoteARCC – Free Report) ."
- According to Zacks on Friday, 28 July, "Direct lending also continues to be increasingly active beyond the arena of the LBO market as direct lenders accomplished 1.5X as non-buyout financings as the broadly syndicated market during the second quarter, according to data by LCD, as quoted on the earnings transcript of Ares Capital (ARCC Quick QuoteARCC – Free Report) ."
4. LGI Homes (LGIH)
18.5% sales growth and 17.75% return on equity
LGI Homes, Inc. designs, constructs, and sells homes in the United States. It offers entry-level homes, such as detached and attached homes, and move-up homes under the LGI Homes brand name; and luxury series homes under the Terrata Homes brand name. As of December 31, 2020, it owned 113 communities. The company serves in Texas, Arizona, Florida, Georgia, New Mexico, Colorado, North Carolina, South Carolina, Washington, Tennessee, Minnesota, Oklahoma, Alabama, California, Oregon, Nevada, West Virginia, Virginia, and Pennsylvania. LGI Homes, Inc. was founded in 2003 and is headquartered in The Woodlands, Texas.
Earnings Per Share
As for profitability, LGI Homes has a trailing twelve months EPS of $11.75.
PE Ratio
LGI Homes has a trailing twelve months price to earnings ratio of 11.84. Meaning, the purchaser of the share is investing $11.84 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.75%.
5. Tetra Technologies (TTI)
18.3% sales growth and 5.3% return on equity
TETRA Technologies, Inc., together with its subsidiaries, operates as an energy services and solutions company. It operates through two segments, Completion Fluids & Products Division and Water & Flowback Services. The Completion Fluids & Products segment manufactures and markets clear brine fluids, additives, and associated products and services to the oil and gas industry for use in well drilling, completion, and workover operations in the United States, as well as in Latin America, Europe, Asia, the Middle East, and Africa. This segment also markets liquid and dry calcium chloride products; and TETRA PureFlow ultra-pure zinc bromide to battery technology companies. The Water & Flowback Services segment provides water management services for onshore oil and gas operators. This segment also offers frac flowback, production well testing, and other associated services in oil and gas producing regions in the United States and Mexico, as well as in various basins in Latin America, Africa, Europe, and the Middle East. The company was incorporated in 1981 and is headquartered in The Woodlands, Texas.
Earnings Per Share
As for profitability, Tetra Technologies has a trailing twelve months EPS of $0.05.
PE Ratio
Tetra Technologies has a trailing twelve months price to earnings ratio of 77.4. Meaning, the purchaser of the share is investing $77.4 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.3%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 60% and 200%, respectively.
Sales Growth
Tetra Technologies’s sales growth is 21.4% for the current quarter and 18.3% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Tetra Technologies’s EBITDA is 24.49.
Revenue Growth
Year-on-year quarterly revenue growth grew by 12.4%, now sitting on 569.39M for the twelve trailing months.
6. Rollins (ROL)
14.6% sales growth and 31.98% return on equity
Rollins, Inc., through its subsidiaries, provides pest and wildlife control services to residential and commercial customers in the United States and internationally. The company offers pest control services to residential properties protecting from common pests, including rodents, insects, and wildlife. It also provides workplace pest control solutions for customers across various end markets, such as healthcare, foodservice, and logistics. In addition, the company offers termite protection services and ancillary services. It serves clients directly, as well as through franchisee operations. Rollins, Inc. was incorporated in 1948 and is headquartered in Atlanta, Georgia.
Earnings Per Share
As for profitability, Rollins has a trailing twelve months EPS of $0.8.
PE Ratio
Rollins has a trailing twelve months price to earnings ratio of 50.76. Meaning, the purchaser of the share is investing $50.76 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 31.98%.
Previous days news about Rollins(ROL)
- Rollins (rol) Q2 earnings: taking a look at key metrics versus estimates. According to Zacks on Friday, 28 July, "Here is how Rollins performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:"
7. Data I/O Corporation (DAIO)
13.7% sales growth and 4.21% return on equity
Data I/O Corporation engages in the design, manufacture, and sale of programming and security deployment systems and services for electronic device manufacturers in the United States, Europe, and internationally. The company's programming system products are used to program integrated circuits (ICs) with the specific data necessary for the ICs. It offers PSV handlers offline automated programming systems; SentriX, a security provisioning system; and RoadRunner and RoadRunner3 series handlers, an in-line automated programming systems. The company also provides LumenX Programmer; non-automated FlashPAK III programming systems; and Unifamily programmers, an offline low volume and engineering non-automated systems. In addition, it provides hardware support, system installation and repair, and device programming services. The company markets and sells its products to original equipment manufacturers in automotive and consumer electronics, Internet of Things and their programming center partners, and electronic manufacturing service contract manufacturers through direct sales, internal telesales, and indirect sales representatives and distributors. Data I/O Corporation was incorporated in 1969 and is headquartered in Redmond, Washington.
Earnings Per Share
As for profitability, Data I/O Corporation has a trailing twelve months EPS of $0.09.
PE Ratio
Data I/O Corporation has a trailing twelve months price to earnings ratio of 47.89. Meaning, the purchaser of the share is investing $47.89 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.21%.
Sales Growth
Data I/O Corporation’s sales growth is 42.2% for the current quarter and 13.7% for the next.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is 100% and a drop 80% for the next.
Yearly Top and Bottom Value
Data I/O Corporation’s stock is valued at $4.31 at 01:23 EST, way under its 52-week high of $4.99 and way higher than its 52-week low of $2.61.
8. United Therapeutics Corporation (UTHR)
5.4% sales growth and 15.66% return on equity
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin, an infused formulation of the prostacyclin analogue treprostinil for subcutaneous and intravenous administration to diminish symptoms associated with exercise in pulmonary arterial hypertension (PAH) patients; Tyvaso, an inhaled formulation of treprostinil to enhance the exercise ability in PAH patients; Orenitram, a tablet dosage form of treprostinil to enhance the exercise capacity in PAH patients; Unituxin, a monoclonal antibody for treating high-risk neuroblastoma; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. The company also engages in developing OreniPro, RemoPro, Tyvaso DPI, Trevyent, Ralinepag, and Aurora-GT to treat PAH; Unexisome to treat bronchopulmonary dysplasia; and the research and development of various organ transplantation-related technologies, including regenerative medicine, xenotransplantation, and ex-vivo lung perfusion, as well as the development of medicine for other diseases. It has licensing and collaboration agreements with Medtronic, Inc. to develop and commercialize the implantable system for Remodulin; Caremark, L.L.C. to provide refills of implanted pumps at its infusion centers; DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of Remodulin; MannKind Corporation to develop and license treprostinil inhalation powder and Dreamboat devices; and Arena Pharmaceuticals, Inc. to develop ralinepag for the treatment of PAH. The company was incorporated in 1996 and is headquartered in Silver Spring, Maryland.
Earnings Per Share
As for profitability, United Therapeutics Corporation has a trailing twelve months EPS of $15.22.
PE Ratio
United Therapeutics Corporation has a trailing twelve months price to earnings ratio of 16.05. Meaning, the purchaser of the share is investing $16.05 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.66%.
Yearly Top and Bottom Value
United Therapeutics Corporation’s stock is valued at $244.34 at 01:23 EST, way under its 52-week high of $283.09 and way above its 52-week low of $201.65.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is 86.7% and a drop 3.1% for the next.
Moving Average
United Therapeutics Corporation’s value is way above its 50-day moving average of $220.98 and higher than its 200-day moving average of $239.42.
